Turnstone Biologics Corp
NASDAQ:TSBX
Intrinsic Value
Turnstone Biologics Corp is a US-based company operating in Biotechnology industry. [ Read More ]
The intrinsic value of one TSBX stock under the Base Case scenario is hidden USD. Compared to the current market price of 2.66 USD, Turnstone Biologics Corp is hidden .
Valuation Backtest
Turnstone Biologics Corp
Run backtest to discover the historical profit from buying and selling TSBX stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Turnstone Biologics Corp
Current Assets | 102.6m |
Cash & Short-Term Investments | 94.8m |
Receivables | 194k |
Other Current Assets | 7.6m |
Non-Current Assets | 10.3m |
PP&E | 9.1m |
Other Non-Current Assets | 1.1m |
Current Liabilities | 12m |
Accounts Payable | 36k |
Accrued Liabilities | 11.9m |
Non-Current Liabilities | 2.2m |
Other Non-Current Liabilities | 2.2m |
Earnings Waterfall
Turnstone Biologics Corp
Revenue
|
19.3m
USD
|
Operating Expenses
|
-78.3m
USD
|
Operating Income
|
-59m
USD
|
Other Expenses
|
3.8m
USD
|
Net Income
|
-55.2m
USD
|
Free Cash Flow Analysis
Turnstone Biologics Corp
TSBX Profitability Score
Profitability Due Diligence
Turnstone Biologics Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Turnstone Biologics Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.
TSBX Solvency Score
Solvency Due Diligence
Turnstone Biologics Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Turnstone Biologics Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TSBX Price Targets Summary
Turnstone Biologics Corp
According to Wall Street analysts, the average 1-year price target for TSBX is 13.26 USD with a low forecast of 6.06 USD and a high forecast of 21 USD.
Ownership
TSBX Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
TSBX Price
Turnstone Biologics Corp
Average Annual Return |
N/A
|
Standard Deviation of Annual Returns |
N/A
|
Max Drawdown | -86% |
Market Capitalization | 61.5m USD |
Shares Outstanding | 23 130 000 |
Percentage of Shares Shorted | 6.44% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Turnstone Biologics Corp is a US-based company operating in Biotechnology industry. The company is headquartered in La Jolla, California and currently employs 108 full-time employees. The company went IPO on 2023-07-21. Turnstone Biologics Corp. is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The firm is focused on developing tumor infiltrating lymphocytes (TIL) therapies designed to drive clinical benefit and curative outcomes across multiple solid tumors. Its selected TIL approach focuses on selecting and expanding potent tumor-reactive T cells to overcome the limitations of bulk TILs. Its pipeline includes TIDAL-01 and TIDAL-02. Its lead selected TIL product candidate, TIDAL-01, utilizes an unbiased identification and functional screening process to isolate and selectively expand the breadth of tumor-reactive TILs from the patient’s tumor. Its next selected TIL program, TIDAL-02, is being designed to encompass a streamlined manufacturing process for tumor-reactive T cells and additional modifications to enhance TIL quality and function.
Contact
IPO
Employees
Officers
The intrinsic value of one TSBX stock under the Base Case scenario is hidden USD.
Compared to the current market price of 2.66 USD, Turnstone Biologics Corp is hidden .